| JYHZ2100057 | 交联玻璃酸钠注射液 | | Injection | Chemical Drugs | License Renew | 2021-03-25 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2021-10-19 | view |
| JYHZ2100058 | 交联玻璃酸钠注射液 | | Injection | Chemical Drugs | License Renew | 2021-03-25 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2021-10-28 | view |
| JYSB2100059 | 兔抗人胸腺细胞免疫球蛋白 | Rabbit Anti-human Thymocyte Immunoglobulin | Lyophilized | Biological Products | Supplementary Application | 2021-02-24 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2022-01-27 | view |
| JYSB2100060 | 兔抗人胸腺细胞免疫球蛋白 | Rabbit Anti-human Thymocyte Immunoglobulin | Lyophilized | Biological Products | Supplementary Application | 2021-02-24 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2021-02-23 | view |
| JYSB2100052 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-02-23 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2021-02-22 | view |
| JXHB2100016 | SAR442168 | tolebrutinib | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2021-01-28 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2021-01-27 | view |
| JXHS2100012 | 注射用奥沙利铂 | oxaliplatin | Lyophilized | Chemical Drugs(2.4) | Import Drug Application | 2021-01-28 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2021-11-02 | view |
| JXHB2100018 | SAR442168 | tolebrutinib | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2021-01-28 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2021-01-27 | view |
| JXHB2100017 | SAR442168 | tolebrutinib | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2021-01-28 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2021-01-27 | view |
| JYSB2100023 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-01-19 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2021-01-18 | view |
| JYSB2100022 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-01-19 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2021-01-18 | view |
| JYHB2100012 | 硫酸羟氯喹片 | hydroxychloroquine sulfate | Tablet | Chemical Drugs | Supplementary Application | 2021-01-07 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Filed | 2021-01-19 | view |
| JYSB2000683 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Supplementary Application | 2021-01-01 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2021-09-22 | view |
| JYSB2000645 | 注射用拉罗尼酶浓溶液 | laronidase | Lyophilized | Biological Products | Supplementary Application | 2020-12-21 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2021-12-23 | view |
| JYHB2002588 | 利鲁唑片 | riluzole | Tablet | Chemical Drugs | Supplementary Application | 2020-12-16 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Filed | 2020-12-25 | view |
| JXSL2000230 | BIVV020注射液 | riliprubart | Injection | Biological Products(1) | Import Drug Application | 2020-12-16 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2020-12-15 | view |
| JYSB2000624 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-14 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Filed | 2020-12-25 | view |
| JYHB2002571 | 硫酸羟氯喹片 | hydroxychloroquine sulfate | Tablet | Chemical Drugs | Supplementary Application | 2020-12-14 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2021-03-17 | view |
| JYSB2000608 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2021-11-16 | view |
| JYSB2000607 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2021-10-21 | view |
